Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2295 (LINC02295) is a human gene that produces a non-coding RNA transcript classified as a lincRNA. LincRNAs are defined as long (over 200 nucleotides), autonomously transcribed RNA molecules that do not overlap protein-coding genes and function primarily through regulatory interactions at the RNA level. The specific biological and disease roles of LINC02295 remain uncharacterized in the literature, but analogous lincRNAs are often implicated in global gene expression control, chromatin remodeling, and cell-type specific regulatory processes[1][3][5].
Not applicable; no drugs are reported to target this molecule directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2295 (LINC02295).